-

MetLife Announces Full Redemption of Series G Preferred Stock

Full Redemption of 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, liquidation preference of $1,000 per share ("Series G Preferred Stock"), at a redemption price of $1,000 per share of Series G Preferred Stock. All outstanding shares of Series G Preferred Stock will be redeemed on the dividend payment date of September 15, 2025.

Regular dividends on the outstanding shares of Series G Preferred Stock of $19.250 per share will be paid separately on September 15, 2025, to holders of record as of the close of business on August 29, 2025, in the customary manner. Accordingly, the redemption price for Series G Preferred Stock will not include any accrued and unpaid dividends. On and after the redemption date, all dividends on the shares of Series G Preferred Stock will cease to accrue.

Series G Preferred Stock is held through The Depository Trust Company ("DTC") and will be redeemed in accordance with the procedures of DTC. Payment to DTC for Series G Preferred Stock will be made by Computershare Trust Company, N.A., as redemption agent. The address for the redemption agent is as follows:

Computershare Trust Company, N.A.
150 Royall Street
Suite 101
Canton, MA 02021

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit metlife.com.

Forward-Looking Statements

The forward-looking statements in this news release, using words such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.

Contacts

For Media:
Jane Slusark
347-989-5477
Jane.Slusark@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

MetLife, Inc.

NYSE:MET

Release Versions

Contacts

For Media:
Jane Slusark
347-989-5477
Jane.Slusark@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

More News From MetLife, Inc.

MetLife Declares Third Quarter 2026 Preferred Stock Dividends

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.31471411 per share on the company’s floating rate noncumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarte...

MetLife Pet Insurance and America's VetDogs Partner to Help Co-Raise Future Service Dog for Veteran or First Responder with Disabilities

NEW YORK--(BUSINESS WIRE)--MetLife Pet Insurance today announced a partnership with America's VetDogs, a national nonprofit that provides service dogs to veterans, first responders and active-duty service members at no cost, to sponsor the dogs’ training and development so that it will one day support a veteran or first responder living with a disability. Through America's VetDogs' Puppy with a Purpose® program, MetLife Pet Insurance will help support the early socialization, basic training and...

MetLife Announces New $3 Billion Share Repurchase Authorization

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $400 million remaining under the company’s prior authorization announced in April 2025. “This new share repurchase authorization reflects our confidence in MetLife’s long-term outlook and continued ability to generate capital,” said MetLife President a...
Back to Newsroom